Wy 48252

Subscribe to Selected New Research on Wy 48252

1 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: leukotriene D4 antagonist

Also Known As:

1,1,1-trifluoro-N-(3-(2-quinolinylmethoxy)phenyl)methane sulfonamide; Wy-48,252; Wy-48252

Bio-Agent Context: Research Results

Heterocyclic Compounds: 23

2-Ring Heterocyclic Compounds

Quinolines: 58

Hydroxyquinolines: 5

Wy 48252: 1

Related Diseases

1.	Hypersensitivity (Allergy) 08/01/1989 - "We conclude that Wy-48,252 is distinguished from other selective LTD4 receptor antagonists by its oral potency and should be useful in ascertaining the role of LTD4 mediated processes in asthma, allergy and animal models." Get all the results and reference details, order at left...
2.	Asthma (Bronchial Asthma) 08/01/1989 - "We conclude that Wy-48,252 is distinguished from other selective LTD4 receptor antagonists by its oral potency and should be useful in ascertaining the role of LTD4 mediated processes in asthma, allergy and animal models." Get all the results and reference details, order at left...
2 Diseases and 1 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Leukotriene D4
2.	leukotriene D4 receptor (cysteinyl leukotriene receptor)
2 Drugs and Important Bio-Agents and 1 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>